Suzhou Bacme Biotech Co., Ltd. which was founded in 2001, is located in a national economic-technological development zone-Taicang Port. The company is a high-tech enterprise which is regarded as the developer, manufacturer, marketer and technical supporter of in-vitro diagnostic reagent produces.

Is one of the first Chinese enterprises which has passed the American FDA GLP inspection, and have a AAALAC (animal welfare) certification and the SFDA GLP certification, the test report provided by Joinn can also achieve the FDA Chinese SFDA recognition.Main Business covers the process of drug discovery until the new drug registration.

Construction in accordance with GMP requirements, will be with an annual capacity of 20 million a freeze-dried needle pronucleus production lines, and 100 kg eukaryotic protein production line and 2000 m2 R&D center. Products field include: tumor, skin repair, ophthalmology, digestive system disease, autoimmune disease, etc.

Biological silicon valley will be constructed professional platform including preclinical research, clinical research, drug registration, Bench- & Pilot-Scale Treatability Testing and new drug transformation.

On April 26, the French President francois hollande have visited the institut Pasteur of Shanghai, Chinese academy of sciences, and witnessed Shanghai Pasteur and Taicang biological medicine industrial park signing the cooperation letter of transfer of scientific and technological achievements transformation.

Committed to the research and development of gene recombination enzyme preparation and the next generation of recombinant protein vaccine product, the core technology platform is protein engineering and mass culture eukaryotic cell production of recombinant protein products.

Suzhou Omni Pharmaceutical Co. Ltd. is a focus on generic formulations in patent and R & D and production company, focusing on research and development of respiratory medication and solid slow release platform. Team: Dr. Zhang Kai, Dr. Zeng Zhaochuan(The original America TEVA company to director of respiratory medicine research center, deputy director) Investors:Eli Lilly Asia, KPCB, Morningside Technology

Located in Tai Cang Technology Pioneer Park, the company is a professional biological medicine R&D outsourcing service company, founded at the end of 2008, with the registered capital of 10 million USDs, for the global pharmaceutical and biotechnology companies provide a full range of tumor and metabolic drug research and development service.

Suzhou SYM-BIO LIFESCIENCE co., LTD, Is founded in Taicang city, which is a wholly owned subsidiary of Shanghai SYM-BIO LIFESCIENCE co., LTD, also has the national drug production license and medical equipment production license, and it not only has become the largest one of in vitro diagnostic reagents in Jiangsu province, but also is China's largest one of luminous class in vitro diagnostic reagents manufacturing enterprises. At present our country already has more than 1000 large and medium-sized hospitals in the use of their products.